SCHEMBL6599314

SCHEMBL6599314

CN(CC(CCN1CCCN(c2nc3ccccc3n2CCS(=O)(=O)c2ccccc2)CC1)c1ccc(Cl)c(Cl)c1)C(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 17/20 0.61
TACR1 P25103 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6595217 0.93 TACR2 (0.63) TACR2TACR1
SCHEMBL6599495 0.92 TACR2 (0.49) TACR2TACR1
SCHEMBL6594100 0.92 TACR2 (0.51) TACR2TACR1
SCHEMBL6595386 0.92 TACR2 (0.47) TACR2TACR1
SCHEMBL6599100 0.90 TACR2 (0.46) TACR2TACR1
SCHEMBL6595763 0.89 LMNA (0.45) TACR2
SCHEMBL6597245 0.89 TACR2 (0.64) TACR2TACR1
SCHEMBL6592210 0.88 TACR2 (0.71) TACR2TACR1
SCHEMBL6599911 0.88 TACR2 (0.63) TACR2TACR1
SCHEMBL6598053 0.88 TACR2 (0.63) TACR2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888338-B1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL) 1,4]DIAZEPAN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES AVENTIS PHARMA INC (US) 2004-11-17 EP disclosed